top of page

Recent Posts

Removing immune 'brake' improves CAR T-cell therapy for pediatric bone cancer

Sep 4

1 min read

Scientists at St. Jude Children's Research Hospital have discovered that removing the gene for Regnase-1 from engineered immune cells makes them more effective at treating relapsed osteosarcoma.

Read more: https://medicalxpress.com/news/2026-08-immune-car-cell-therapy-pediatric.html

Trial provides first look at long-term outcomes of childhood immunotherapies

“Lower-Risk” Childhood Cancer May Be More Dangerous Than It Appears

Largest study supports three courses of radiation for children with deadly brain tumor

Unraveling how a deadly childhood cancer spreads could keep it in its place

Unraveling how immune aging influences health outcomes for survivors of childhood blood cancers

Unexpected discovery points to a possible route for childhood brain tumor treatments

Turning Pediatric Cancer Discoveries Into Medicines Requires Better Connections

Removing immune 'brake' improves CAR T-cell therapy for pediatric bone cancer

Cardiometabolic Risk in Childhood Cancer Survivors Treated With Anthracyclines

Hodgkin Lymphoma Survivors Face Higher Long-Term Mortality

Archive

Search By Tags

bottom of page